BIOMAT Database Logo BIOMAT Database Logo

Pituitary apoplexy following the administration of gonadotrophin releasing hormone. 1994

M Korsić

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D010899 Pituitary Apoplexy The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA. Apoplexy, Pituitary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Korsić
Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone.
January 1993, Clinical endocrinology,
M Korsić
Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma.
March 2015, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
M Korsić
Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.
October 1997, Journal of endocrinological investigation,
M Korsić
[Pituitary apoplexy after injection of pituitary-hormone releasing hormones].
May 1994, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Korsić
Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.
September 2010, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
M Korsić
Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.
January 2016, Endocrinology, diabetes & metabolism case reports,
M Korsić
Pituitary apoplexy following isosorbide administration.
May 1987, Journal of neurology, neurosurgery, and psychiatry,
M Korsić
Mechanism of action of gonadotrophin-releasing hormone on pituitary gonadotrophin secretion.
January 1989, Journal of reproduction and fertility. Supplement,
M Korsić
Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
December 1998, Human reproduction (Oxford, England),
M Korsić
Pulsatile administration of gonadotrophin releasing hormone as a diagnostic tool to distinguish hypothalamic from pituitary hypogonadism following neurosurgery.
November 1993, Human reproduction (Oxford, England),
Copied contents to your clipboard!